Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma.

[1]  M. Schwaiger,et al.  Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Danny Rischin,et al.  Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  R. Cerfolio,et al.  Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma. , 2003, The Journal of thoracic and cardiovascular surgery.

[4]  A. Fischman,et al.  Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.

[5]  D. Lee,et al.  Determination of the prognostic value of [18F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer , 2002, Nuclear medicine communications.

[6]  F. Schramel,et al.  Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer. , 2002, The Annals of thoracic surgery.

[7]  M. Boers,et al.  Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial , 2002, The Lancet.

[8]  L. Freitag,et al.  [Recommendations on the therapy of bronchial carcinoma]. , 2002, Pneumologie.

[9]  A. Fischman,et al.  FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. , 2002, Lung cancer.

[10]  S. Reske,et al.  FDG-PET for clinical use , 2001, European Journal of Nuclear Medicine.

[11]  Hak Choy,et al.  Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. , 2001, The Annals of thoracic surgery.

[12]  D. Hellwig,et al.  [Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000]. , 2001, Pneumologie.

[13]  R. Giudicelli,et al.  Postoperative complications in relation with induction therapy for lung cancer. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  Y. Erdi,et al.  FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection , 2001, European Journal of Nuclear Medicine.

[15]  H. Schäfers,et al.  Bronchial and bronchovascular sleeve resection for treatment of central lung tumors. , 2000, The Annals of thoracic surgery.

[16]  U. Gatzemeier,et al.  [Recommendations on the diagnosis of bronchial carcinoma. German Pneumology Society]. , 2000, Pneumologie.

[17]  R. Attanoos,et al.  ACP Best Practice No 161. Examination of lung specimens , 2000, Journal of clinical pathology.

[18]  John E. Connolly,et al.  Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. , 2000, AJR. American journal of roentgenology.

[19]  P. Dupont,et al.  Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  P. Dupont,et al.  Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  R. Coleman,et al.  The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma , 1998, Cancer.

[22]  C. Mountain,et al.  Regional lymph node classification for lung cancer staging. , 1997, Chest.

[23]  M. Sasaki,et al.  A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma , 1996, Annals of nuclear medicine.

[24]  R. Hardoff,et al.  Uptake of gallium-67 citrate and [2-3H]deoxyglucose in the tumor model, following chemotherapy and radiotherapy. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  N. Altorki,et al.  Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer. , 2004, The Annals of thoracic surgery.

[26]  H. Schäfers,et al.  Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. , 2003, The Annals of thoracic surgery.

[27]  W. Dörr.  Normal tissue reactions in radiotherapy and oncology , 2002 .

[28]  C. Rübe,et al.  Comparison of early pulmonary changes in 18FDG-PET and CT after combined radiochemotherapy for advanced non-small-cell lung cancer: a study in 15 patients. , 2002, Frontiers of radiation therapy and oncology.

[29]  Yukiko Arisaka,et al.  18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  S. Larson,et al.  An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. , 2002, The Annals of thoracic surgery.

[31]  A. Hogg,et al.  High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. , 2001, International journal of radiation oncology, biology, physics.

[32]  R. Attanoos,et al.  Examination of lung specimens , 1990 .